Top-News
Mittwoch,
26.02.2014 14:35
von
PR Newswire
| Aufrufe: 169
Hop-on Subsidiary Re-Medical Enters into Cannabis Transdermal Delivery
Eine Wissenschaftlerin bei einer Untersuchung. (Symbolbild)
© Stas_Uvarov / iStock / Getty Images Plus / Getty Images
http://www.gettyimages.de/
PR Newswire
TEMECULA, Calif., Feb. 26, 2014
TEMECULA, Calif., Feb. 26, 2014 /PRNewswire/ -- Hop-on, Inc (OTC:HPNN.PK) announced today its subsidiary, Re-Medical, Inc., is setting up distribution of cannabis transdermal patches in legal jurisdictions, with the first being Colorado.
Re-Medical's mission is to provide solutions for patients desiring to use cannabis as a nutraceutical alternative to traditional or prescription medications.
Re-Medical is a Hop-on company focused on alternative ways to deliver vitamins, supplements and other healthful products such as cannabis, utilizing transdermal patches. The company has developed and isolated the benefits of cannabis and other vital plant extracts for best patient care. There are an estimated 80+ cannabinoids found in cannabis, each providing distinctive neuropathic effects. The company is currently applying for patents regarding the delivery of cannabis via transdermal patches. Re-Medical patches offer cost effective, accurate and clean delivery of these unique compounds.
Re-Medical's transdermal patch has a variety of choices for both high THC and high CBD cannabis users to medicate in a precisely dosed, discreet, clean delivery method. Re-Medical offers the high THC and high CBD transdermal patches in 10mg and 20mg doses.
Hop-on, Inc. (HPNN.PK) is a global ODM and OEM manufacturer of electronics, based in the United States. Over the past 20 years, Hop-on has successfully secured essential patents for mobile communications and computing technologies, and is respected for developing the world's first disposable cell phone. Hop-on's focus on smartphones and innovative mobile device applications is bringing cost friendly solutions to today's demanding world market. Hop-on is also diversified in delivering cannabis remedies. For more information, please visit www.re-medical.com
For more information: email
Contact person: Peter Michaels 949-756-9008
Read more news from Hop-on, Inc.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
SOURCE Hop-on, Inc.
Werbung
Mehr Nachrichten zur Hop-On Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
